X
CONE

Xponance’s CyrusOne Inc Common Stock CONE Stock Holding History

Xponance’s Portfolio CONE Stock Details CONE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,130
Closed -$1.27M – 1198
2021
Q4 		$1.27M Buy
14,130
+191
+1% +$16.2K 0.02% 518
2021
Q3 		$1.08M Sell
13,939
-349
-2% -$26.2K 0.02% 524
2021
Q2 		$1.02M Buy
14,288
+1,597
+13% +$116K 0.02% 583
2021
Q1 		$859K Buy
12,691
+51
+0.4% +$3.54K 0.02% 532
2020
Q4 		$925K Buy
12,640
+278
+2% +$20.2K 0.02% 484
2020
Q3 		$866K Buy
12,362
+1,890
+18% +$148K 0.02% 452
2020
Q2 		$762K Buy
+10,472
New +$746K 0.02% 449

Other funds holding CONE

JCM
Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return
KA
Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Xponance's CONE Position: Q1 2022 in Review

Xponance sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 14,130 shares — an estimated $1.27M sold.

Xponance first reported a position in CONE in Q2 2020 and held it in 7 quarters. The position peaked at $1.27M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Xponance reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Xponance sold 14,130 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $1.27M.
  • Xponance first reported a position in CyrusOne Inc Common Stock in Q2 2020 and held it in 7 quarters.
  • Xponance's CyrusOne Inc Common Stock position peaked at $1.27M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.